Please assess the completion status of the following clinical trial:

Trial Title: Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose Data

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults over 18 years of age~* Type 1 diabetes confirmed on the basis of clinical features and a fasting c-peptide \<200 pmol/L~* Severe hypoglycaemic event in the last 12 months requiring third party assistance OR a Gold Score ≥ 4~* Type 1 diabetes for greater than 3 years~* On an intensified multiple dose insulin injection regimen for \> 6 months (MDI)~* Previous type 1 diabetes structured education (either group or 1:1)~Exclusion Criteria:~* Use of CGM or Libre device within the last 6 months (except short periods of diagnostic blinded use under clinic supervision)~* Use of regular paracetamol~* Pregnant or planning pregnancy~* Breastfeeding~* Enrolled in other clinical trials, except at the discretion of the chief investigator~* Have active malignancy or under investigation for malignancy~* Severe visual impairment~* Reduced manual dexterity~* Unable to participate due to other factors, as assessed by the Chief Investigators

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Real time continuous glucose monitoring (Type: ACTIVE_COMPARATOR): Use of Dexcom G5 continuous glucose monitoring
- Flash glucose monitoring (Type: ACTIVE_COMPARATOR): Use of Abbott FreeStyle Libre flash glucose monitoring

Based on this trial design, predict the completion outcome and termination type (if applicable).